United Parcel Service has agreed to pay a $40 million fine for their failure to stop fake online pharmacies from using their service. They have also agreed to implement safeguards in the shipping systems going forward to prevent drug counterfeiters from using UPS to ship their products.
On March 29, 2013, the US Department of Justice announced a non-prosecution agreement with United Parcel Service (UPS) in which UPS agrees to pay a fine of $40 million to the Federal government, and also implement compliance procedures to ensure they no longer ship illicit and counterfeit drugs for illegal online pharmacies, reports Fox Business.
According to the Department of Justice (DOJ), “UPS has cooperated fully with the investigation and has already taken steps to ensure that illegal Internet pharmacies can no longer use its services to ship drugs. These voluntary improvements will be strengthened by the compliance program UPS will implement as a condition of this NPA.”
Billing Insurance Companies for Imported Drugs is a Crime In November 2012, Tennessee oncologist William Kincaid pled guilty to purchasing cancer drugs from unauthorized distributors who were hawking counterfeit drugs with no active ingredient. Dr. Kincaid deprived his patients of needed cancer treatments and endangered their lives, but–as with Al Capone–the Federal government’s case against him…
Special agents with the US Immigration and Customs Enforcement Homeland Security Investigations (ICE-HIS) seized approximately $ 4 million worth of counterfeit goods and pharmaceuticals in South Carolina.
The seizure was the result of an investigation that began February 19th. Investigators from ICE-HSI, the South Carolina Secretary of State’s Office, Blazer Investigations and Pfizer found a stockpile of counterfeit goods in a warehouse in Columbia. The bulk of the seized counterfeit items were counterfeit pharmaceuticals, according to the ICE.
The FDA has released photographs of a portable XRF analyzer designed to screen dietary supplements for toxic metals. The device is one of a new generation of portable screening tools, which will allow investigators to discover and seize adulterated drugs before they are available to consumers. The FDA’s new efforts rely on spectroscopic technologies that “analyze the dispersion of an object’s light determine the object’s chemical or molecular composition.”
The Mexican Senate voted on March 12 to increase penalties to counterfeit drug sellers to nine years in prison and fines of up to 3 million pesos.
The Senate approved an amendment to article 464 of The General Health Law to increase penalties with 90 votes in favor. Senate Health Committee President Maki Esther Ortiz Dominguez said, “Anyone who sells or offers for sale, trades, distributes or transports medicine, drugs, raw materials that are falsified, altered, contaminated or adulterated, either in stores or in any other place….will be subject to the same penalty,” reported The News.
Last month, the United Nations Office on Drugs and Crime (UNODC) held a conference in Vienna to discuss the the production, distribution and trafficking of fake drugs by organized crime networks. The conference, which was held February 14-15, gathered an international group of experts from governments, law enforcement agencies, NGOs and the private sector to share information about the scale of the problem, which has significant impact worldwide. UNODC has found that in parts of Asia, Africa and Latin America as much as 30 percent of available drugs are fraudulent, and that the trafficking of unsafe or ineffective medicine is “a multi-billion dollar activity.”
March
12, 2013 (Washington, D.C.) – The Partnership for Safe Medicines
(PSM), the leading advocacy organization dedicated to fighting the spread of
counterfeit drugs, applauds today’s
announcement of a bold new initiative between INTERPOL
and the pharmaceutical industry to combat the global health threat of
counterfeit and fake medicines.
This new initiative broadens the scope of the
successful Medical Product Counterfeiting and Pharmaceutical Crime Unit through
the creation of a Pharmaceutical Crime Program to assist and enhance worldwide
law enforcement efforts. Thomas Kubic, PSM Board Member and CEO of the
Pharmaceutical Security Institute, released the following statement hailing the
new agreement:
How Did That Canadian Web Pharmacy Medicine Get to Me?
So called “Canadian” online pharmacies pretend to sell non-Canadians price-controlled medications for citizens. Evidence collected by the U.S. Food and Drug Administration questions their claim.
Though China has long been linked to the manufacture of counterfeit drugs, the last two years have shown that Chinese authorities are taking counterfeit drug crime much more seriously. China’s Food and Drug Administration (SFDA) cracked over 14,000 cases last year, a major toxic gel capsule ring was broken up, and Chinese authorities are working in concert with both the FDA and major drug manufacturers to track down counterfeit drug manufacturers and prosecute them. The founding of Partnership for Safe Medicines China also demonstrates China’s stakeholders’ commitment to improving patient safety both at home and abroad.
China made great strides in the last year in their efforts to combat pharmaceutical counterfeiting. Their cooperation with the US Food and Drug Administration on inspections is helping to safeguard both US and Chinese consumers. The founding of Partnership for Safe Medicines China underscores a new commitment to ensuing drug safety within their borders. Partnership for Safe Medicines China is the latest branch of the leading advocacy organization dedicated to fighting the global threat posed by counterfeit and misbranded drugs.
The National Association of Boards of Pharmacy (NABP) has released their 5th annual report on Internet Drug Outlets. Published each year, it is a progress report for state and federal regulators that illustrates the state of online drug sales in the United States and the overwhelming dominance of fake online pharmacies in the global Internet marketplace.
As of March 4, 2011, NABP surveyed 10,275 internet pharmacies and found that 9,938 or 97% were classified as “Not Recommended”, meaning they did not comply with NABP patient safety and pharmacy practice standards, or state and federal laws.